Semaglutide and other GLP-1 agonists actually improve glucose metabolism but work through appetite suppression rather than direct fat cell targeting
Similar increases in resting heart rate have been documented with liraglutide (Saxenda) and semaglutide (Wegovy/Ozempic), as noted in their respective UK Summaries of Product Characteristics (SmPCs) available via the Electronic Medicines Compendium (eMC)
It is therefore tempting to speculate if the intestinotrophic effects of GLP-1 and GLP-2 receptor agonists, leading to increased nutrient absorptive area, could stimulate colonization of mucosa-associated microbial communities
Some people maintain results at 30 grams of carbs
Meaning that, you know, there's a group of people, it's more than 50%, but that are gonna have, you know, a good response and that's gonna be their drug, that's gonna be the key to their mast cell or the key to their condition